Back to Journals » Patient Preference and Adherence » Volume 3

A pilot program at the worksite to reduce adverse self-medication behaviors

Authors Neafsey P, Lutkus G, Newcomb J, Anderson E

Published 20 August 2009 Volume 2009:3 Pages 277—286

DOI https://doi.org/10.2147/PPA.S6188

Review by Single-blind

Peer reviewer comments 2

Patricia J Neafsey1,2, Gregory Lutkus2, Jessica Newcomb2, Elizabeth Anderson1,2

1Center for Health Intervention and Prevention (CHIP); 2School of Nursing, University of Connecticut, Storrs, CT, USA

Abstract: A Next Generation Personal Education Program (PEP-NG) that captures self-reported medication behaviors and delivers a tailored educational intervention on a touchscreen interface was piloted with 11 adults with hypertension, aged 45–60 years, in a worksite setting. A time series design with multiple institution of treatment (four visits over three months) was employed. Blood pressure (BP), self-medication behaviors, self-efficacy, and knowledge for avoiding adverse self-medication behaviors were assessed at each of four visits. Satisfaction was assessed once at visit 4. Measures pre-PEP (visit 1) to visit 4 were compared with paired t-tests. The adverse self-medication behavior risk score decreased significantly from visit 1 to visit 4 (p < 0.05) with a medium effect size. Both knowledge and self-efficacy for avoiding adverse self-medication behaviors increased significantly (p < 0.05) with large effect sizes. All six participants not at BP goal (<140/90 mmHg) on visit 1 were at goal by visit 4. User satisfaction was high as assessed by both quantitative measures and qualitative interviews. These positive results suggest the PEP could play a central role in worksite wellness programs aimed at workers with hypertension.

Keywords: hypertension, worksite, information technology, tailored intervention

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]